Control of pharmacokinetic profiles of drug-macromolecule conjugates

Yoshinobu Takakura, Ram I. Mahato, Makiya Nishikawa, Mitsuru Hashida

Research output: Contribution to journalReview article

56 Citations (Scopus)

Abstract

Macromolecular conjugation is a useful method for controlling the pharmacokinetic profiles of small drugs, proteins, oligonucleotides and genes. Site-specific drug delivery can be achieved by the use of an appropriate macromolecular carrier which should have an affinity for the target tissue or cells. The rationale of this approach is to alter the disposition characteristics of a free drug by conjugating it to a suitable macromolecular carrier. The rational design of drug-macromolecule conjugates requires a thorough understanding of the relationship between their chemical structures, physicochemical properties and pharmacokinetics at whole body, organ, cellular and subcellular levels. In this article, the current status and future perspectives of macromolecular conjugates of conventional low molecular weight drugs, protein drugs and gene medicines, such as antisense oligonucleotides and plasmid DNA, are reviewed.

Original languageEnglish (US)
Pages (from-to)377-399
Number of pages23
JournalAdvanced Drug Delivery Reviews
Volume19
Issue number3
DOIs
StatePublished - Jun 12 1996

Fingerprint

Pharmacokinetics
Pharmaceutical Preparations
Antisense Oligonucleotides
Drug Design
Oligonucleotides
Proteins
Plasmids
Molecular Weight
DNA

Keywords

  • Antitumor drugs
  • DNA drugs
  • Macromolecular conjugate
  • Pharmacokinetics
  • Protein drugs
  • Targeting

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Control of pharmacokinetic profiles of drug-macromolecule conjugates. / Takakura, Yoshinobu; Mahato, Ram I.; Nishikawa, Makiya; Hashida, Mitsuru.

In: Advanced Drug Delivery Reviews, Vol. 19, No. 3, 12.06.1996, p. 377-399.

Research output: Contribution to journalReview article

Takakura, Yoshinobu ; Mahato, Ram I. ; Nishikawa, Makiya ; Hashida, Mitsuru. / Control of pharmacokinetic profiles of drug-macromolecule conjugates. In: Advanced Drug Delivery Reviews. 1996 ; Vol. 19, No. 3. pp. 377-399.
@article{6bc797d8192249eb97c0e519b17bdeef,
title = "Control of pharmacokinetic profiles of drug-macromolecule conjugates",
abstract = "Macromolecular conjugation is a useful method for controlling the pharmacokinetic profiles of small drugs, proteins, oligonucleotides and genes. Site-specific drug delivery can be achieved by the use of an appropriate macromolecular carrier which should have an affinity for the target tissue or cells. The rationale of this approach is to alter the disposition characteristics of a free drug by conjugating it to a suitable macromolecular carrier. The rational design of drug-macromolecule conjugates requires a thorough understanding of the relationship between their chemical structures, physicochemical properties and pharmacokinetics at whole body, organ, cellular and subcellular levels. In this article, the current status and future perspectives of macromolecular conjugates of conventional low molecular weight drugs, protein drugs and gene medicines, such as antisense oligonucleotides and plasmid DNA, are reviewed.",
keywords = "Antitumor drugs, DNA drugs, Macromolecular conjugate, Pharmacokinetics, Protein drugs, Targeting",
author = "Yoshinobu Takakura and Mahato, {Ram I.} and Makiya Nishikawa and Mitsuru Hashida",
year = "1996",
month = "6",
day = "12",
doi = "10.1016/0169-409X(96)00010-5",
language = "English (US)",
volume = "19",
pages = "377--399",
journal = "Advanced Drug Delivery Reviews",
issn = "0169-409X",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Control of pharmacokinetic profiles of drug-macromolecule conjugates

AU - Takakura, Yoshinobu

AU - Mahato, Ram I.

AU - Nishikawa, Makiya

AU - Hashida, Mitsuru

PY - 1996/6/12

Y1 - 1996/6/12

N2 - Macromolecular conjugation is a useful method for controlling the pharmacokinetic profiles of small drugs, proteins, oligonucleotides and genes. Site-specific drug delivery can be achieved by the use of an appropriate macromolecular carrier which should have an affinity for the target tissue or cells. The rationale of this approach is to alter the disposition characteristics of a free drug by conjugating it to a suitable macromolecular carrier. The rational design of drug-macromolecule conjugates requires a thorough understanding of the relationship between their chemical structures, physicochemical properties and pharmacokinetics at whole body, organ, cellular and subcellular levels. In this article, the current status and future perspectives of macromolecular conjugates of conventional low molecular weight drugs, protein drugs and gene medicines, such as antisense oligonucleotides and plasmid DNA, are reviewed.

AB - Macromolecular conjugation is a useful method for controlling the pharmacokinetic profiles of small drugs, proteins, oligonucleotides and genes. Site-specific drug delivery can be achieved by the use of an appropriate macromolecular carrier which should have an affinity for the target tissue or cells. The rationale of this approach is to alter the disposition characteristics of a free drug by conjugating it to a suitable macromolecular carrier. The rational design of drug-macromolecule conjugates requires a thorough understanding of the relationship between their chemical structures, physicochemical properties and pharmacokinetics at whole body, organ, cellular and subcellular levels. In this article, the current status and future perspectives of macromolecular conjugates of conventional low molecular weight drugs, protein drugs and gene medicines, such as antisense oligonucleotides and plasmid DNA, are reviewed.

KW - Antitumor drugs

KW - DNA drugs

KW - Macromolecular conjugate

KW - Pharmacokinetics

KW - Protein drugs

KW - Targeting

UR - http://www.scopus.com/inward/record.url?scp=0030580955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030580955&partnerID=8YFLogxK

U2 - 10.1016/0169-409X(96)00010-5

DO - 10.1016/0169-409X(96)00010-5

M3 - Review article

AN - SCOPUS:0030580955

VL - 19

SP - 377

EP - 399

JO - Advanced Drug Delivery Reviews

JF - Advanced Drug Delivery Reviews

SN - 0169-409X

IS - 3

ER -